Helicos BioSciences Cuts 40 Jobs Amid Restructuring | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Helicos BioSciences said after the close of the market on Monday that it has cut 40 jobs this quarter as part of a consolidation and reorganization of its business.

The Cambridge, Mass.-based maker of a single-molecule sequencing platform said that around half of the company's remaining 40 employees are supported by National Institutes of Health funding for research aimed at improving its technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: transcriptional and translational study of human cytomegalovirus interactions with host cells, spider web DNA study, and more.

The New York Stem Cell Foundation signs a lease for a new space.

Researchers gear up for an international meeting to discuss the ethics of gene editing.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.